|
1
|
Hossain MS, Urbi Z, Sule A and Hafizur
Rahman KM: Andrographis paniculata (Burm. f.) Wall. ex Nees:
A review of ethnobotany, phytochemistry, and pharmacology.
ScientificWorldJournal. 2014(274905)2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Davis C, Chan BY, Zhen Ong AS, Koh Y, Wen
Yap AFH, Goh SH and Vidyarthi AR: An evaluation of a medical
student international service-learning experience in Southeast
Asia. Educ Health (Abingdon). 34:3–10. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jadhav AK and Karuppayil SM:
Andrographis paniculata (Burm F) Wall ex Nees: Antiviral
properties. Phytother Res. 35:5365–5373. 2021.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Sa-Ngiamsuntorn K, Suksatu A, Pewkliang Y,
Thongsri P, Kanjanasirirat P, Manopwisedjaroen S,
Charoensutthivarakul S, Wongtrakoongate P, Pitiporn S, Chaopreecha
J, et al: Anti-SARS-CoV-2 activity of Andrographis
paniculata extract and its major component andrographolide in
human lung epithelial cells and cytotoxicity evaluation in major
organ cell representatives. J Nat Prod. 84:1261–1270.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kumar RA, Sridevi K, Kumar NV, Nanduri S
and Rajagopal S: Anticancer and immunostimulatory compounds from
Andrographis paniculata. J Ethnopharmacol. 92:291–295.
2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rajagopal S, Kumar RA, Deevi DS,
Satyanarayana C and Rajagopalan R: Andrographolide, a potential
cancer therapeutic agent isolated from Andrographis
paniculata. J Exp Ther Oncol. 3:147–158. 2003.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ahmad S, Ahmad S, Arshad M and Afzal M:
Andrographia paniculata a miracle herbs for cancer
treatment: In vivo and in vitro studies against aflatoxin B1
toxicity. Egypt J Med Hum Genet. 15:163–171. 2014.
|
|
8
|
Li L, Yue GG, Lee JK, Wong EC, Fung KP, Yu
J, Lau CB and Chiu PW: The adjuvant value of Andrographis
paniculata in metastatic esophageal cancer treatment-from
preclinical perspectives. Sci Rep. 7(854)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hodroj MH, Jardaly A, Abi Raad S, Zouein A
and Rizk S: Andrographolide potentiates the antitumor effect of
topotecan in acute myeloid leukemia cells through an intrinsic
apoptotic pathway. Cancer Manag Res. 10:1079–1088. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Malik Z, Parveen R, Parveen B, Zahiruddin
S, Aasif Khan M, Khan A, Massey S, Ahmad S and Husain SA:
Anticancer potential of andrographolide from Andrographis
paniculata (Burm.f.) Nees and its mechanisms of action. J
Ethnopharmacol. 272(113936)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lee YC, Lin HH, Hsu CH, Wang CJ, Chiang TA
and Chen JH: Inhibitory effects of andrographolide on migration and
invasion in human non-small cell lung cancer A549 cells via
down-regulation of PI3K/Akt signaling pathway. Eur J Pharmacol.
632:23–32. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Amatu A, Sartore-Bianchi A and Siena S:
NTRK gene fusions as novel targets of cancer therapy across
multiple tumour types. ESMO Open. 1(e000023)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chi HT, Ly BT, Kano Y, Tojo A, Watanabe T
and Sato Y: ETV6-NTRK3 as a therapeutic target of small molecule
inhibitor PKC412. Biochem Biophys Res Commun. 429:87–92.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Knezevich SR, McFadden DE, Tao W, Lim JF
and Sorensen PH: A novel ETV6-NTRK3 gene fusion in congenital
fibrosarcoma. Nat Genet. 18:184–187. 1998.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tognon C, Knezevich SR, Huntsman D,
Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F,
MacPherson N, Horsman D, et al: Expression of the ETV6-NTRK3 gene
fusion as a primary event in human secretory breast carcinoma.
Cancer Cell. 2:367–376. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Eguchi M, Eguchi-Ishimae M, Tojo A,
Morishita K, Suzuki K, Sato Y, Kudoh S, Tanaka K, Setoyama M,
Nagamura F, et al: Fusion of ETV6 to neurotrophin-3 receptor TRKC
in acute myeloid leukemia with t(12;15)(p13;q25). Blood.
93:1355–1363. 1999.PubMed/NCBI
|
|
17
|
Setoyama M, Tojo A, Nagamura F, Asano S,
Ishimae M, Eguchi M and Kamada N: A unique translocation of the
gene in a case of acute myelogenous leukemia with inv(12)(p13q15).
Blood. 92:1454–1455. 1998.PubMed/NCBI
|
|
18
|
Skálová A, Vanecek T, Sima R, Laco J,
Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RH,
Passador-Santos F, et al: Mammary analogue secretory carcinoma of
salivary glands, containing the ETV6-NTRK3 fusion gene: A hitherto
undescribed salivary gland tumor entity. Am J Surg Pathol.
34:599–608. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Forghieri F, Morselli M, Potenza L,
Maccaferri M, Pedrazzi L, Paolini A, Bonacorsi G, Artusi T,
Giacobbi F, Corradini G, et al: Chronic eosinophilic leukaemia with
ETV6-NTRK3 fusion transcript in an elderly patient affected with
pancreatic carcinoma. Eur J Haematol. 86:352–355. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rubin BP, Chen CJ, Morgan TW, Xiao S,
Grier HE, Kozakewich HP, Perez-Atayde AR and Fletcher JA:
Congenital mesoblastic nephroma t(12;15) is associated with
ETV6-NTRK3 gene fusion: Cytogenetic and molecular relationship to
congenital (infantile) fibrosarcoma. Am J Pathol. 153:1451–1458.
1998.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Leeman-Neill RJ, Kelly LM, Liu P, Brenner
AV, Little MP, Bogdanova TI, Evdokimova VN, Hatch M, Zurnadzy LY,
Nikiforova MN, et al: ETV6-NTRK3 is a common chromosomal
rearrangement in radiation-associated thyroid cancer. Cancer.
120:799–807. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Solomon JP, Benayed R, Hechtman JF and
Ladanyi M: Identifying patients with NTRK fusion cancer. Ann Oncol.
30 (Suppl 8):viii16–viii22. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lapeña LM, Caldas MCS, Ramírez C, Basilio
MS, Junco PT, Rodríguez-Laguna L, Martínez-González V,
Marín-Manzano E, Perez-Martinez A and Lopez-Gutierrez JC:
Larotrectinib as an effective therapy in congenital infantile
fibrosarcoma: Report of two cases. European J Pediatr Surg Rep.
10:e76–e79. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ernst MS, Lysack JT, Hyrcza MD, Chandarana
SP and Hao D: TRK inhibition with entrectinib in metastatic
salivary secretory carcinoma (SC): A case report. Curr Oncol.
29:3933–3939. 2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chi HT, Thuong NTL and Ly BTK:
Sphagneticola trilobata (L.) Pruski (asteraceae) methanol extract
induces apoptosis in leukemia cells through suppression of BCR/ABL.
Plants (Basel). 10(980)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ly BT, Chi HT, Yamagishi M, Kano Y, Hara
Y, Nakano K, Sato Y and Watanabe T: Inhibition of FLT3 expression
by green tea catechins in FLT3 mutated-AML cells. PLoS One.
8(e66378)2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ala AA, Olotu BB and Ohia CMD: Assessment
of cytotoxicity of leaf extracts of Andrographis paniculata
and Aspilia africana on murine cells in vitro. Arch Basic Appl Med.
6:61–65. 2018.PubMed/NCBI
|
|
28
|
Mahavorasirikul W, Viyanant V,
Chaijaroenkul W, Itharat A and Na-Bangchang K: Cytotoxic activity
of Thai medicinal plants against human cholangiocarcinoma,
laryngeal and hepatocarcinoma cells in vitro. BMC Complement Altern
Med. 10(55)2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Iijima Y, Okuda K, Tojo A, Tri NK,
Setoyama M, Sakaki Y, Asano S, Tokunaga K, Kruh GD and Sato Y:
Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG.
Oncogene. 21:4374–4383. 2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ziegler U and Groscurth P: Morphological
features of cell death. News Physiol Sci. 19:124–128.
2004.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Doonan F and Cotter TG: Morphological
assessment of apoptosis. Methods. 44:200–204. 2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tognon C, Garnett M, Kenward E, Kay R,
Morrison K and Sorensen PH: The chimeric protein tyrosine kinase
ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling
for fibroblast transformation. Cancer Res. 61:8909–8916.
2001.PubMed/NCBI
|
|
33
|
Vaishnavi A, Le AT and Doebele RC: TRKing
down an old oncogene in a new era of targeted therapy. Cancer
Discov. 5:25–34. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Vaishnavi A, Capelletti M, Le AT, Kako S,
Butaney M, Ercan D, Mahale S, Davies KD, Aisner DL, Pilling AB, et
al: Oncogenic and drug-sensitive NTRK1 rearrangements in lung
cancer. Nat Med. 19:1469–1472. 2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Nagasubramanian R, Wei J, Gordon P,
Rastatter JC, Cox MC and Pappo A: Infantile fibrosarcoma with
NTRK3-ETV6 fusion successfully treated with the tropomyosin-related
kinase inhibitor LOXO-101. Pediatr Blood Cancer. 63:1468–1470.
2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Doebele RC, Davis LE, Vaishnavi A, Le AT,
Estrada-Bernal A, Keysar S, Jimeno A, Varella-Garcia M, Aisner DL,
Li Y, et al: An oncogenic NTRK fusion in a patient with soft-tissue
sarcoma with response to the tropomyosin-related kinase inhibitor
LOXO-101. Cancer Discov. 5:1049–1057. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhou F and Chen B: Acute myeloid leukemia
carrying ETV6 mutations: Biologic and clinical features.
Hematology. 23:608–612. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Chao WW and Lin BF: Isolation and
identification of bioactive compounds in Andrographis
paniculata (Chuanxinlian). Chin Med. 5(17)2010.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Cheung HY, Cheung SH, Li J, Cheung CS, Lai
WP, Fong WF and Leung FM: Andrographolide isolated from
Andrographis paniculata induces cell cycle arrest and
mitochondrial-mediated apoptosis in human leukemic HL-60 cells.
Planta Med. 71:1106–1111. 2005.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lin HH, Tsai CW, Chou FP, Wang CJ, Hsuan
SW, Wang CK and Chen JH: Andrographolide down-regulates
hypoxia-inducible factor-1α in human non-small cell lung cancer
A549 cells. Toxicol Appl Pharmacol. 250:336–345. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Suzuki R, Matsushima Y, Okudaira N,
Sakagami H and Shirataki Y: Cytotoxic components against human oral
squamous cell carcinoma isolated from Andrographis
paniculata. Anticancer Res. 36:5931–5935. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Anoor PK, Yadav AN, Rajkumar K, Kande R,
Tripura C, Naik KS and Burgula S: Methanol extraction revealed
anticancer compounds quinic acid, 2(5H)-furanone and phytol in
Andrographis paniculata. Mol Clin Oncol.
17(151)2022.PubMed/NCBI View Article : Google Scholar
|
